Literature DB >> 30116656

The role of dermoscopy in a topical steroid-damaged face.

Sidharth Sonthalia1, Abhijeet K Jha2, Reena Sharma3.   

Abstract

Entities:  

Keywords:  dermoscopy; steroid abuse; topical steroid-damaged face

Year:  2018        PMID: 30116656      PMCID: PMC6092079          DOI: 10.5826/dpc.0803a02

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


× No keyword cloud information.
A 29-year old male presented with pinkish-red erythema over the cheeks with patchy brown discoloration and grossly visible telangiectasias of 6 months’ duration (Figure 1). He also complained about his facial skin being very sensitive, especially to sun exposure. The patient was aware that he had melasma and gave a history of occasional use of sunscreen in the past. Despite repeated and persuasive questioning, he staunchly denied applying any topical steroid-containing formulations or depigmenting creams. Polarized dermoscopic examination (EScope; Nakoda, ×20) of the cheeks revealed a reddish-brown background, brown dots, globules and clods, multiple tortuous and branching linear vessels and telangiectasias, and ivory white-to-strawberry ice cream colored patches in addition to conspicuous hypertrichosis (Figure 2A–2B). Suspecting topical steroid abuse, he was shown the dermoscopic features on the computer screen and cautioned about the complications of “topical steroid-damaged face.” He finally admitted to having used a mometasone-containing triple combination cream over the cheeks twice a day for the previous 4 months, at the suggestion of a friend. Since his last examination, the patient has been using a broad-spectrum sunscreen on a daily basis, topical vitamin 20% serum and has been scheduled for intense pulsed light therapy for facial rejuvenation.
Figure 1

Clinical picture of the patient showing pinkish-red erythema over the cheeks with patchy brown discoloration and grossly visible telangiectasias. [Copyright: ©2018 Sonthalia et al.]

Figure 2

(A, B) Dermoscopy of the cheek revealing reddish-brown background, brown dots, globules and clods (black arrows) suggestive of a background of melasma, multiple tortuous and branching linear vessels (white arrows), telangiectasias and ivory white-to-strawberry-colored patches (blue arrow) suggestive of skin atrophy, in addition to conspicuous hypertrichosis (Escope, videodermoscope, polarizing mode, 20×). [Copyright: ©2018 Sonthalia et al.]

Prominent telangiectasias, ivory white-to-strawberry-colored patches (suggestive of skin atrophy) and lesional hypertrichosis constitute dermoscopic features which are indicative of “topical steroid-damaged face,” while the brown pigmented structures suggest a background of melasma. The abuse of topical steroid-containing formulations over the face has now been well established as a dermatological nuisance in India [1].

Conclusions

Through this report, we wish to highlight that many of these patients are in a denial about their steroid abuse. Importantly, dermoscopy not only noninvasively confirms the suspicion, but also aids in the patient’s understanding of the seriousness of topical steroid abuse through the demonstration of pictures explained in patient-friendly language. In the majority of cases it also ensures further steroid abuse and improves treatment compliance [2].
  2 in total

1.  Dermoscopy - Not just for diagnosis and not just for Dermatologists !

Authors:  S Sonthalia; E Errichetti
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2017 Jan.-Mar.

Review 2.  Side-effects of topical steroids: A long overdue revisit.

Authors:  Arijit Coondoo; Meghana Phiske; Shyam Verma; Koushik Lahiri
Journal:  Indian Dermatol Online J       Date:  2014-10
  2 in total
  1 in total

1.  Dermoscopy assisted topical steroid-dependent/damaged face (TSDF) severity score (DATS Score): Reliability assessment and validation of a new scoring method.

Authors:  Sheenam Sethi; Rashmi Jindal; Payal Chauhan
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.